Condition category
Mental and Behavioural Disorders
Date applied
30/09/2004
Date assigned
30/09/2004
Last edited
29/05/2012
Prospective/Retrospective
Retrospectively registered
Overall trial status
Stopped
Recruitment status
Stopped

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Mr Rami Jumnoodoo

ORCID ID

Contact details

Trust
Park Royal MH Centre
Twyford Centre
Acton lane
Central Way
London
NW10 7NS
United Kingdom
+44 (0)208 453 2779
rami.jumnoodoo@nhs.net

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N0195129515

Study information

Scientific title

Acronym

Study hypothesis

Whether a prescribed course of relapse prevention therapy (RPT), based on Marlatts model, may have a statistically significant higher knowledge score post-group; whether there will be a significant reduction of inpatient bed nights and whether there will be a statistically significant degree of contact maintenance with helping services by comparison with the comparison group?

Ethics approval

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Other

Trial type

Treatment

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet

Condition

Mental and Behavioural Disorders: Schizophrenia

Intervention

For the experimental group, there will be a semi structured interview questionnaire at pre and post relapse prevention therapy (RPT) and at 5 weeks follow up. For the control group, there will be a semi structured questionnaire to be completed at the same time as that of the experimental group and afterwards at 3 months interval to ensure matching time intervals. In addition there will be a demographic characteristic form to complete on ever participant.

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

Relapse prevention skills and knowledge, reduction of in-patient hospitalisation and an improvement in maintaining contact with helping services.

Secondary outcome measures

Not provided at time of registration

Overall trial start date

08/07/2002

Overall trial end date

16/06/2003

Reason abandoned

Lack of staff/facilities/resources

Eligibility

Participant inclusion criteria

Patients with a primary diagnosis of schizophrenia (International Statistical Classification of Diseases and Related Health Problems - tenth revision [ICD10] = F20-29)

Participant type

Patient

Age group

Not Specified

Gender

Not Specified

Target number of participants

Not provided at time of registration

Participant exclusion criteria

Does not meet inclusion criteria

Recruitment start date

08/07/2002

Recruitment end date

16/06/2003

Locations

Countries of recruitment

United Kingdom

Trial participating centre

Trust
London
NW10 7NS
United Kingdom

Sponsor information

Organisation

Department of Health

Sponsor details

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Sponsor type

Government

Website

http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Other

Funder name

London West Mental R&D Consortium (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes